ASCT2 overexpression is associated with poor survival of OSCC patients and ASCT2 knockdown inhibited growth of glutamine‐addicted OSCC cells
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ASCT2 overexpression is associated with poor survival of OSCC patients and ASCT2 knockdown inhibited growth of glutamine‐addicted OSCC cells
Authors
Keywords
-
Journal
Cancer Medicine
Volume 9, Issue 10, Pages 3489-3499
Publisher
Wiley
Online
2020-03-12
DOI
10.1002/cam4.2965
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CCL2 promotes cell migration by inducing epithelial‐mesenchymal transition in oral squamous cell carcinoma
- (2019) Zihang Ling et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- Glutaminolysis‐related genes determine sensitivity to xCT‐targeted therapy in head and neck squamous cell carcinoma
- (2019) Shogo Okazaki et al. CANCER SCIENCE
- Disrupting Mitochondrial Pyruvate Uptake Directs Glutamine into the TCA Cycle away from Glutathione Synthesis and Impairs Hepatocellular Tumorigenesis
- (2019) Sean C. Tompkins et al. Cell Reports
- ASC amino acid transporter 2, defined by enzyme-mediated activation of radical sources, enhances malignancy of GD2-positive small-cell lung cancer
- (2018) Nobutoshi Esaki et al. CANCER SCIENCE
- The role of ASCT2 in cancer: A review
- (2018) Yang Liu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- CD164 promotes tumor progression and predicts the poor prognosis of bladder cancer
- (2018) Xiao-Guang Zhang et al. Cancer Medicine
- Metabolic Reprogramming in Modulating T Cell Reactive Oxygen Species Generation and Antioxidant Capacity
- (2018) Josephin N. Rashida Gnanaprakasam et al. Frontiers in Immunology
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- American Joint Committee on Cancer staging system 7th edition versus 8th edition: any improvement for patients with squamous cell carcinoma of the tongue?
- (2018) Marco Mascitti et al. Oral Surgery Oral Medicine Oral Pathology Oral Radiology
- Glutathione de novo synthesis but not recycling process coordinates with glutamine catabolism to control redox homeostasis and directs murine T cell differentiation
- (2018) Gaojian Lian et al. eLife
- FOXP3 inhibits MYC expression via regulating miR-198 and influences cell viability, proliferation and cell apoptosis in HepG2
- (2018) Xiaohui Duan et al. Cancer Medicine
- Prognostic implications of peritumoral vasculature in head and neck cancer
- (2018) Michael Evans et al. Cancer Medicine
- Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target
- (2016) M. Bolzoni et al. BLOOD
- ASCT2 (SLC1A5) is an EGFR-associated protein that can be co-targeted by cetuximab to sensitize cancer cells to ROS-induced apoptosis
- (2016) Haiquan Lu et al. CANCER LETTERS
- Expression of Metabolism-Related Proteins in Lacrimal Gland Adenoid Cystic Carcinoma
- (2015) Ja Seung Koo et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Phase II trial of everolimus in patients with refractory metastatic adenocarcinoma of the esophagus, gastroesophageal junction and stomach: possible role for predictive biomarkers
- (2015) Zev A. Wainberg et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Glutaminolysis and carcinogenesis of oral squamous cell carcinoma
- (2015) Marcel Cetindis et al. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
- Targeting ASCT2-mediated glutamine uptake blocks prostate cancer growth and tumour development
- (2015) Qian Wang et al. JOURNAL OF PATHOLOGY
- Rethinking glutamine addiction
- (2015) Abigail S. Krall et al. NATURE CELL BIOLOGY
- ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer
- (2015) M van Geldermalsen et al. ONCOGENE
- Expression of Amino Acid Transporters (LAT1 and ASCT2) in Patients with Stage III/IV Laryngeal Squamous Cell Carcinoma
- (2015) Osamu Nikkuni et al. PATHOLOGY & ONCOLOGY RESEARCH
- ASC amino-acid transporter 2 (ASCT2) as a novel prognostic marker in non-small cell lung cancer
- (2014) K Shimizu et al. BRITISH JOURNAL OF CANCER
- Prognostic significance of amino-acid transporter expression (LAT1, ASCT2 and xCT) in surgically resected tongue cancer
- (2014) M Toyoda et al. BRITISH JOURNAL OF CANCER
- Clinicopathological significance of ASC amino acid transporter-2 expression in pancreatic ductal carcinoma
- (2014) Kyoichi Kaira et al. HISTOPATHOLOGY
- Targeting glutamine transport to suppress melanoma cell growth
- (2014) Qian Wang et al. INTERNATIONAL JOURNAL OF CANCER
- Glutamine addiction: a new therapeutic target in cancer
- (2010) David R. Wise et al. TRENDS IN BIOCHEMICAL SCIENCES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search